BKIDC-1553
BKIDC-1553 is an orally bioavailable small molecule with an approximate 17-hour human half-life. This bumped kinase inhibitor-derived compound acts as an antiglycolytic agent and inhibits CYP2C8 and Angiotensin Converting Enzyme. It is utilized in cancer research for in vitro and in vivo studies targeting tumor metabolism and signaling pathways.
Product Specifications
CAS Number
1951431-34-7
Field of Research
Metabolism Research
Smiles
NC1=C2C (=NN (CC (C) (C) O) C2=NC=N1) C3=CC4=C (C=C3) C=C (OC5CC5) C=C4
Molecular Formula
C22H23N5O2
Molecular Weight
389.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
226421-01 50 µL
TPSG1 (Tryptase gamma, Tryptase y, Tryptase-y, Serine Protease 31, Transmembrane tryptase, Tryptase gamma Light Chain, Tryptase gamma Heavy Chain, PRSS31, TMT) discontinued
Sign In for Pricing
View Details 226421-02 100 µL
TPSG1 (Tryptase gamma, Tryptase y, Tryptase-y, Serine Protease 31, Transmembrane tryptase, Tryptase gamma Light Chain, Tryptase gamma Heavy Chain, PRSS31, TMT) discontinued
Sign In for Pricing
View Details 